AgPlus diagnostics

AgPlus Diagnostics is a cutting-edge company specialising in the development and provision of a portable diagnostic solution, Agilis Reader. Servicing multiple markets, the focus of AgPlus Diagnostics is to offer a point of care (PoC) solution that rivals fixed laboratory analyzers in functionality while offering the advantages of portability. Powering the company's vision is the goal of enabling better, faster, and more accurate diagnoses, paving the way for truly personalised care.

Known for its innovative and market-leading technology, AgPlus Diagnostics' diagnostic reader and successfully developed assays have distinguished features that set it apart from other PoC platform providers. The technology behind the company's offerings involves a complex process using silver nanoparticles and antibodies. Furthermore, its diagnostic reader is also protected by patent rights. In addition to its primary product, the company offers a variety of services such as contract development and manufacturing. The company addresses many healthcare industry challenges, including devolved and remote healthcare, support for an aging population, emergency testing in hospital environments, and the rising occurrence of infectious diseases due to growing antimicrobial resistance.

AgPlus Diagnostics is a company to watch because its mission is focused on delivering improved solutions for healthcare professionals and their patients globally. The company's dedicated team of experienced professionals aims to bring better outcomes in patient care. With a desire to share their market-leading technology with customers, the company welcomes interest and partnerships from organisations looking to license their patent-protected technology. In the rapidly evolving healthcare industry, AgPlus Diagnostics is playing a vital role in revolutionising patient care through portable diagnostic readers.

Connect